The substitution of Val-62 with Ile changes the complement component of the C3b binding site, modifying complement pathways and systemic levels of Ba, C3d and C3d/C3 ratio with a potentially protective impact in AMD [28,46,47]. The gene discussed is C3; the disease is age-related macular degeneration.